| Filed | 
                                    Name | 
                                     | 
                                    Company | 
                                    Pur. £ | 
                                    Cur. £ | 
                                    P/L % | 
                                    MPV* | 
                                
                                
                                
                                                                                                                
                                                | 
                                                    Jun '22
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Sugar
                                                 | 
                                                                                                     | 
                                                                                                
                                                    Acl / NMS:ACLX                                                  | 
                                                
                                                    £17.47
                                                 | 
                                                
                                                    £87.50
                                                 | 
                                                                                                                                                                                                                
                                                    400.86%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £350,601.05
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Mar '24
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Moynihan of Chelsea
                                                 | 
                                                                                                     | 
                                                                                                
                                                    Candel Therapeutics / NGM:CADL                                                  | 
                                                
                                                    £1.40
                                                 | 
                                                
                                                    £5.58
                                                 | 
                                                                                                                                                                                                                
                                                    298.57%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £279,000.00
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    May '22
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Reay
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Novo Nordisk As / NYQ:NVO                                                  | 
                                                
                                                    £56.40
                                                 | 
                                                
                                                    £140.80
                                                 | 
                                                                                                                                                                                                                
                                                    149.67%
                                                 | 
                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                        £174,767.27**
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Mar '24
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Moynihan of Chelsea
                                                 | 
                                                                                                     | 
                                                                                                
                                                    Tg Therapeutics / NCM:TGTX                                                  | 
                                                
                                                    £15.05
                                                 | 
                                                
                                                    £34.02
                                                 | 
                                                                                                                                                                                                                
                                                    126.05%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £158,232.56
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Dec '22
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Hintze
                                                 | 
                                                                                                     | 
                                                                                                
                                                    Atai Life Sciences / NGM:ATAI                                                  | 
                                                
                                                    £3.48
                                                 | 
                                                
                                                    £5.78
                                                 | 
                                                                                                                                                                                                                
                                                    66.09%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £116,264.37
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    May '22
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Triesman
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Blue / NMS:BLUE                                                  | 
                                                
                                                    £3.39
                                                 | 
                                                
                                                    £4.97
                                                 | 
                                                                                                                                                                                                                
                                                    46.61%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £102,625.36
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Mar '24
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Moynihan of Chelsea
                                                 | 
                                                                                                     | 
                                                                                                
                                                    Mustang Bio / NCM:MBIO                                                  | 
                                                
                                                    £1.04
                                                 | 
                                                
                                                    £1.46
                                                 | 
                                                                                                                                                                                                                
                                                    40.38%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £98,269.23
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Apr '21
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Baroness Deech
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Novo Nordisk As / NYQ:NVO                                                  | 
                                                
                                                    £36.35
                                                 | 
                                                
                                                    £50.04
                                                 | 
                                                                                                                                                                                                                
                                                    37.66%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £96,363.14
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Mar '24
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Moynihan of Chelsea
                                                 | 
                                                                                                     | 
                                                                                                
                                                    Fortress Biotech / NCM:FBIO                                                  | 
                                                
                                                    £1.92
                                                 | 
                                                
                                                    £2.57
                                                 | 
                                                                                                                                                                                                                
                                                    33.85%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £93,697.91
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Jul '25
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Fink
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Avacta Group / LSE:AVCT.L                                                  | 
                                                
                                                    £51.50
                                                 | 
                                                
                                                    £68.00
                                                 | 
                                                                                                                                                                                                                
                                                    32.04%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £92,427.18
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Nov '21
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Sherbourne of Didsbury
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Novo Nordisk As / NYQ:NVO                                                  | 
                                                
                                                    £56.71
                                                 | 
                                                
                                                    £70.73
                                                 | 
                                                                                                                                                                                                                
                                                    24.73%
                                                 | 
                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                        £87,313.29**
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Mar '24
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Petitgas
                                                 | 
                                                                                                     | 
                                                                                                
                                                    Royalty Pharma / NMS:RPRX                                                  | 
                                                
                                                    £30.08
                                                 | 
                                                
                                                    £36.94
                                                 | 
                                                                                                                                                                                                                
                                                    22.81%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £85,964.09
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Apr '22
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Hylton
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Genus / LSE:GNS.L                                                  | 
                                                
                                                    £2,678.00
                                                 | 
                                                
                                                    £2,485.00
                                                 | 
                                                                                                                                                                                                                
                                                    -7.21%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £64,955.19
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Jan '21
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Spencer of Alresford
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Immupharma / LSE:IMM.L                                                  | 
                                                
                                                    £12.65
                                                 | 
                                                
                                                    £11.30
                                                 | 
                                                                                                                                                                                                                
                                                    -10.67%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £62,529.65
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Jun '16
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Lloyd-Webber
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Bb Biotech / EBS:BION.SW                                                  | 
                                                
                                                    £47.80
                                                 | 
                                                
                                                    £41.25
                                                 | 
                                                                                                                                                                                                                
                                                    -13.70%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £60,407.95
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Mar '14
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Glendonbrook
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Bb Biotech / EBS:BION.SW                                                  | 
                                                
                                                    £33.36
                                                 | 
                                                
                                                    £27.20
                                                 | 
                                                                                                                                                                                                                
                                                    -18.47%
                                                 | 
                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                        £57,074.34**
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Nov '24
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Moynihan of Chelsea
                                                 | 
                                                                                                     | 
                                                                                                
                                                    Sab Biotherapeutics / NCM:SABS                                                  | 
                                                
                                                    £3.95
                                                 | 
                                                
                                                    £3.01
                                                 | 
                                                                                                                                                                                                                
                                                    -23.80%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £53,341.77
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Mar '17
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Lloyd-Webber
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Bb Biotech / EBS:BION.SW                                                  | 
                                                
                                                    £54.95
                                                 | 
                                                
                                                    £41.25
                                                 | 
                                                                                                                                                                                                                
                                                    -24.93%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £52,547.77
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Aug '23
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Nash
                                                 | 
                                                                                                     | 
                                                                                                
                                                    Relay / NGM:RLAY                                                  | 
                                                
                                                    £10.62
                                                 | 
                                                
                                                    £7.34
                                                 | 
                                                                                                                                                                                                                
                                                    -30.89%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £48,380.42
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    May '23
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Stevens of Ludgate
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Avacta Group / LSE:AVCT.L                                                  | 
                                                
                                                    £112.00
                                                 | 
                                                
                                                    £68.00
                                                 | 
                                                                                                                                                                                                                
                                                    -39.29%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £42,500.00
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Apr '24
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Grabiner
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Novo Nordisk As / NYQ:NVO                                                  | 
                                                
                                                    £127.46
                                                 | 
                                                
                                                    £64.73
                                                 | 
                                                                                                                                                                                                                
                                                    -49.22%
                                                 | 
                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                        £35,549.19**
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Nov '23
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Mance
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Novo Nordisk As / NYQ:NVO                                                  | 
                                                
                                                    £101.69
                                                 | 
                                                
                                                    £50.04
                                                 | 
                                                                                                                                                                                                                
                                                    -50.79%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £34,445.86
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Apr '22
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Spencer of Alresford
                                                 | 
                                                                                                     | 
                                                                                                
                                                    Oxford Nanopore / LSE:ONT.L                                                  | 
                                                
                                                    £320.00
                                                 | 
                                                
                                                    £136.50
                                                 | 
                                                                                                                                                                                                                
                                                    -57.34%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £29,859.38
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Apr '24
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Willoughby de Broke
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Novo Nordisk As / NYQ:NVO                                                  | 
                                                
                                                    £122.75
                                                 | 
                                                
                                                    £50.04
                                                 | 
                                                                                                                                                                                                                
                                                    -59.23%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £28,536.05
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    May '24
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Londesborough
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Novo Nordisk As / NYQ:NVO                                                  | 
                                                
                                                    £134.66
                                                 | 
                                                
                                                    £50.04
                                                 | 
                                                                                                                                                                                                                
                                                    -62.84%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £26,012.18
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Mar '24
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Petitgas
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Moderna / NMS:MRNA                                                  | 
                                                
                                                    £111.98
                                                 | 
                                                
                                                    £28.14
                                                 | 
                                                                                                                                                                                                                
                                                    -74.87%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £17,590.64
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Sep '21
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Darzi of Denham
                                                 | 
                                                                                                     | 
                                                                                                
                                                    Oxford Nanopore / LSE:ONT.L                                                  | 
                                                
                                                    £612.60
                                                 | 
                                                
                                                    £136.50
                                                 | 
                                                                                                                                                                                                                
                                                    -77.72%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £15,597.45
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Oct '15
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Hayward
                                                 | 
                                                                                                     | 
                                                                                                
                                                    Sage / NGM:SAGE                                                  | 
                                                
                                                    £46.11
                                                 | 
                                                
                                                    £8.68
                                                 | 
                                                                                                                                                                                                                
                                                    -81.18%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £13,177.19
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    May '11
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Glendonbrook
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Mesoblast / NMS:MESO                                                  | 
                                                
                                                    £101.20
                                                 | 
                                                
                                                    £16.43
                                                 | 
                                                                                                                                                                                                                
                                                    -83.76%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £11,364.63
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    May '20
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Wolfson of Aspley Guise
                                                 | 
                                                                                                     | 
                                                                                                
                                                    Adc Therapeutics / NYQ:ADCT                                                  | 
                                                
                                                    £30.00
                                                 | 
                                                
                                                    £4.63
                                                 | 
                                                                                                                                                                                                                
                                                    -84.57%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £10,803.33
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Apr '19
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Nash
                                                 | 
                                                                                                     | 
                                                                                                
                                                    Eq / NCM:EQ                                                  | 
                                                
                                                    £8.20
                                                 | 
                                                
                                                    £0.69
                                                 | 
                                                                                                                                                                                                                
                                                    -91.59%
                                                 | 
                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                        £5,890.24**
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Mar '24
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Moynihan of Chelsea
                                                 | 
                                                                                                     | 
                                                                                                
                                                    Avenue Therapeutics / NCM:ATXI                                                  | 
                                                
                                                    £12.00
                                                 | 
                                                
                                                    £0.72
                                                 | 
                                                                                                                                                                                                                
                                                    -94.04%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £4,172.00
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Mar '23
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Baroness Shields
                                                 | 
                                                                                                     | 
                                                                                                
                                                    Benevolentai / AMS:BAI.AS                                                  | 
                                                
                                                    £2.46
                                                 | 
                                                
                                                    £0.09
                                                 | 
                                                                                                                                                                                                                
                                                    -96.14%
                                                 | 
                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                        £2,703.25**
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Mar '24
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Moynihan of Chelsea
                                                 | 
                                                                                                    
                                                         
                                                     | 
                                                                                                
                                                    Adaptimmune / NMS:ADAP                                                  | 
                                                
                                                    £1.47
                                                 | 
                                                
                                                    £0.05
                                                 | 
                                                                                                                                                                                                                
                                                    -96.54%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £2,419.05
                                                    
                                                 | 
                                            
                                                                                
                                                | 
                                                    Dec '22
                                                 | 
                                                
                                                                                                                                                                                                                     
                                                    Lord Hintze
                                                 | 
                                                                                                     | 
                                                                                                
                                                    Affimed / NGM:AFMD                                                  | 
                                                
                                                    £21.20
                                                 | 
                                                
                                                    £0.00
                                                 | 
                                                                                                                                                                                                                
                                                    -100.00%
                                                 | 
                                                
                                                                                                                                                                                                                                                                    
                                                        £0.33
                                                    
                                                 | 
                                            
                                                                                                    
                            
                            * Minimum Potential Value based on £70,000.00 invested at time of declaration.
                            ** Interest ceased/exited on filed date.